The landmark Diabetes Prevention Program, led by the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), found that people with prediabetes can reduce their risk for type 2 diabetes by more than half. The ongoing TrialNet study screen thousands of relatives of people with type 1 diabetes every year and conducts prevention studies to help learn how to predict and reduce the incidence of type 1 diabetes in this population. These are only two examples among many of research that has the potential to change - and save - lives. The NIDDK's National Diabetes Information Clearinghouse (NDIC) supports the NIDDK mission by developing and promoting research-based health information and campaigns for the public. Among many publications, Am I at Risk for Type 2 Diabetes? helps people understand and lower their likelihood of getting type 2 diabetes. The A1C Test and Diabetes explains an important test of a person's average level of blood glucose and how the test can help with diagnosis and management of diabetes. The NIDDK, a component of the National Institutes of Health (NIH), conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition and obesity; and kidney, urologic and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans. For more information about the NIDDK and its programs, see http://www.niddk.nih.gov....

Diabetes; For National Diabetes Month, NIH urges actions to reach health goals